PET-CT for Breast Cancer: — When Is It Actually Needed?

Ask what specific finding they expect it to reveal and how that finding would change your treatment. If you have stage I or II disease and the concern is distant spread, guidelines suggest that finding is unlikely at your stage. If a previous scan gave an unclear result, or there is a specific clinical reason your team is worried about, the recommendation may be well founded. When in doubt, a second opinion from a breast cancer specialist is reasonable.

For early-stage breast cancer, the standard workup uses mammogram and ultrasound to assess the tumour and nearby lymph nodes, breast MRI where the team needs more detail on disease extent in the breast, and in some cases a CT of the chest and abdomen. A bone scan may be added if there is bone pain or another high-risk feature. This combination gives your team what they need for stages I and II without the additional cost of PET-CT.

Yes. PET-CT is not designed to examine breast tissue in detail, and it can miss small tumours or low-grade cancers that are not metabolically active enough to appear on the scan. Mammogram, ultrasound and MRI are better tools for assessing the primary tumour in the breast. PET-CT's strength is in looking across the whole body for spread — it is a staging and response-assessment tool, not a substitute for breast-specific imaging.

Not in itself. PET-CT is ordered when your team needs specific information — often about spread or treatment response — that other scans have not clearly provided. In breast cancer, that question most often arises in locally advanced disease, metastatic disease or recurrence, which is why the scan tends to appear at those points. Being referred for one means your team is being thorough. It does not tell you what the result will be.

Costs vary by city and centre, and any figure quoted here would quickly become outdated. CION coordinates PET-CT through partner imaging centres, and your care coordinator can give you a current cost estimate for the centre nearest to you. If cost is a concern, raise it with your oncologist — in some situations a CT and bone scan together can answer the same clinical question at lower cost, depending on what your team is looking for.

Quite possibly. Recurrence is one of the clearest situations where PET-CT adds real value. When breast cancer returns, your team needs to know whether it has come back in one place or in several — because that determines whether treatment should target a single site or address spread across the body. A PET-CT can map that picture across the whole body in one session. Your oncologist will decide based on how and where the recurrence was found.